Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes

Loading...
Thumbnail Image

Date

Journal Title

Journal ISSN

Volume Title

Publisher

Dove Medical Press Ltd.

Abstract

Description

Keywords

Benzoates, Chelation therapy, Deferoxamine, Drug therapy, combination, Humans, Iron, Iron chelating agents, Pyridones, Syndrome, Thalassemia, Triazoles, Deferasirox, Deferiprone, Benzoic acid derivative, Iron chelating agent, Pyridone derivative, Triazole derivative, Article, Drug efficacy, Drug safety, Drug tolerability, Heart hemosiderosis, Human, Iron chelation, Iron overload, Postmarketing surveillance, Thalassemia major, Chemically induced, Combination drug therapy

Citation

Endorsement

Review

Supplemented By

Referenced By